Details for New Drug Application (NDA): 077764
✉ Email this page to a colleague
NDA 077764 describes APRACLONIDINE HYDROCHLORIDE, which is a drug marketed by Rising and is included in one NDA. Additional details are available on the APRACLONIDINE HYDROCHLORIDE profile page.
The generic ingredient in APRACLONIDINE HYDROCHLORIDE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.
The generic ingredient in APRACLONIDINE HYDROCHLORIDE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.
Summary for 077764
| Tradename: | APRACLONIDINE HYDROCHLORIDE |
| Applicant: | Rising |
| Ingredient: | apraclonidine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.5% BASE | ||||
| Approval Date: | Mar 12, 2009 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
